Amedisys (NASDAQ:AMED) earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed ...

Amedisys (NASDAQ:AMED) rose 1% in after hours trading after a divestiture agreement in its planned sale to UnitedHealth (NYSE:UNH) that may help it secure regulatory approval after the Dept. of ...

UnitedHealth Group and Amedisys have found buyers for key divestitures aimed at getting their $3.3 billion merger over the ...

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the Department of Justice sued to block the deal last year. Amedisys delivers ...

The U.S. Department of Justice (DOJ) has reportedly rejected Amedisys’ (Nasdaq: AMED) and UnitedHealth Group’s (NYSE: UNH) attempt to divest assets, a ...

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the ...

For those who have been following the U.S. Department of Justice’s (DOJ) legal battle against UnitedHealth Group (NYSE: UNH) and Amedisys Inc. (NASDAQ: ...

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.

BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Three-Month Periods Ended ...

Amedisys (NASDAQ:AMED) earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed divestiture buyers for its planned sale to UnitedHealth (NYSE:UNH).